These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3013339)

  • 1. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation.
    Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Wahren B
    Blood; 1986 Jul; 68(1):108-12. PubMed ID: 3013339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins A, G, and M to cytomegalovirus during recurrent infection in recipients of allogeneic bone marrow transplantation.
    Engelhard D; Weinberg M; Or R; Shaked O; Naparstek E; Haikin H; Slavin S; Sarov I
    J Infect Dis; 1991 Mar; 163(3):628-30. PubMed ID: 1847402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity related to cytomegalovirus after allogenic bone marrow transplantation: role of donor immunity to cytomegalovirus in the incidence of cytomegalovirus infection in recipients].
    Rabian-Herzog C; Varrin F; Gluckmann E; Bertrand C; Harzic M; Ferchal F
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):331-6. PubMed ID: 6091224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus-specific in vitro antibody production by peripheral blood lymphocytes from renal transplant recipients with CMV infection.
    Segondy M; Barat L; Mourad G; Huguet MF; Serre A; Vendrell JP
    J Med Virol; 1993 Jul; 40(3):200-3. PubMed ID: 8394872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the measurement of virus-specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value?
    Milburn HJ; Grundy JE; du Bois RM; Prentice HG; Griffiths PD
    J Med Virol; 1988 Oct; 26(2):197-206. PubMed ID: 2846778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.
    Schmeiser T; Heit W; Arnold R; Bunjes D; Wiesneth M; Hertenstein B; Hampl W; Heimpel H
    Klin Wochenschr; 1987 Oct; 65(20):967-74. PubMed ID: 2828758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
    Boland GJ; Vlieger AM; Ververs C; De Gast GC
    Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological diagnosis of cytomegalovirus-induced interstitial pneumonia in patients following bone marrow transplantation].
    Müller A; Pustowoit B; Arnold U; Hoffmann FA; Kubel M; Raue I; Friedrich T
    Z Gesamte Inn Med; 1991 Aug; 46(12):443-6. PubMed ID: 1659048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
    Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
    J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections.
    O'Neill HJ; Shirodaria PV; Connolly JH; Simpson DI; McGeown MG
    J Med Virol; 1988 Apr; 24(4):461-70. PubMed ID: 2835436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus excretion after bone marrow transplantation cannot be predicted from the pre-transplant level of IgG antibodies.
    Pillay D; Webster A; Lee D; Prentice HG; Griffiths PD
    J Med Virol; 1991 Apr; 33(4):257-9. PubMed ID: 1649910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
    Landini MP; Rossier E; Schmitz H
    J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
    Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
    Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
    Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipients.
    Panjwani DD; Ball MG; Berry NJ; Wimperis JZ; Blacklock HA; Prentice HG; Hoffbrand AV; Griffiths PD
    J Med Virol; 1985 Aug; 16(4):357-65. PubMed ID: 2993504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG-subclass-specific CMV reactivity in bone marrow transplant recipients.
    Wahren B; Linde A; Sundqvist VA; Ljungman P; Lönnqvist B; Ringdén O
    Transplantation; 1984 Nov; 38(5):479-83. PubMed ID: 6093297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.